Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-Risk Cancer × Neoadjuvant Therapy × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Rectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Surgery 1 Stomach Neoplasms 1 Stage III and IV Ovarian Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Squamous Cell Carcinoma of External Auditory Canal 1 Solitary Fibrous Tumor, Pleural 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡